DNTH — DIANTHUS THERAPEUTICS INC

Ownership history in Alphabet Inc.  ·  9 quarters on record

This page tracks every 13F SEC filing in which Alphabet Inc. reported a position in DIANTHUS THERAPEUTICS INC (DNTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.34% (2025 Q3)
Avg. % of fund
0.24%
First filed
2023 Q3
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 208,697 — 0% 0.34% $8.2M $39.35
2025 Q2 UNCHANGED 208,697 — 0% 0.18% $3.9M $18.63
2025 Q1 UNCHANGED 208,697 — 0% 0.24% $3.8M $18.14
2024 Q4 UNCHANGED 208,697 — 0% 0.26% $4.5M $21.80
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DNTH price (monthly, adj. close)

Other funds also holding DNTH

As of 2025 Q4 — sorted by position size

Avidity Partners Management LP 3Y 25.01% Octagon Capital Advisors LP 3Y 12.09% Fairmount Funds Management LLC 3Y 6.7% Catalio Capital Management, LP 4.76% GREAT POINT PARTNERS LLC 3Y 7Y 4.68% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 4.29% Tri Locum Partners LP 3Y 3.33% Sio Capital Management, LLC 3Y 7Y 3.08% Bain Capital Life Sciences Investors, LLC 3Y 7Y 2.35% TCG Crossover Management, LLC 3Y 2.29%
← Back to Alphabet Inc. Holdings